United Ali Health to create an "Internet plus vaccine" platform, Koxing's new crown vaccine is a step further.

Today, Ali Health and biopharmaceutical company Koxing Holding Biotechnology Co., Ltd. ("Koxing Holdings") signed a strategic cooperation agreement, the two sides will focus on the "Internet plus vaccine" digital platform, vaccine online appointment, vaccine process traceability, post-vaccination health follow-up, vaccine science education and other areas of cooperation.
Under the agreement, Cossing Holdings will use Ali Health's Internet platform to carry out digital medical, large health industry upgrades, traceability codes, vaccine appointment extension services and other businesses, and Ali Health will use The company's advantages in vaccine products and related resources to help its vaccine business development.
, the cooperation also includes the construction of a new coronavirus vaccine (the "new crown vaccine") vaccination platform.
platform includes online appointments for the new crown vaccine, matching of seedling information based on Ali's health traceability code, follow-up of post-vaccination health status, and issuance of vaccination certificates.
, some high-risk exposed people have been able to use the platform to achieve vaccination appointments and follow-up services for the new crown vaccine.
It is learned that Kexing Holdings subsidiary Beijing Kexing Zhongwei Biotechnology Co., Ltd., is the world's first enterprise to complete the experimental research on animals of the new crown vaccine, which on January 28 launched a related vaccine development project called "Operation Crown", in cooperation with the CDC of Zhejiang Province, the Institute of Medical Experimental Animals of the Chinese Academy of Medical Sciences, the Institute of Microbiology of the Academy of Sciences, the Institute of Biophysics of the Chinese Academy of Sciences, the Wuhan Institute of Viruses of the Chinese Academy of Sciences and other units, according to the "war-time state" and jointly promote the development of vaccine technology.
present, the new crown vaccine developed by Koxing Zhongwei has completed phase I./II. clinical research in China, and is steadily advancing phase III. clinical research in Brazil, Indonesia, Turkey and other countries.
and Coxing Zhongwei has completed the construction of vaccine industrialization and has been put into production, the annual design capacity of more than 300 million doses.
two weeks ago, at the 2020 China International Trade fair in china, Kexing Holdings showed off a new coronavirus inactivated vaccine, Kelleford.
this time with Ali Health, Koxing Holdings is mainly for the follow-up to the commercial consideration of the new crown vaccine.
After the launch of the new crown vaccine, Ali Health will continue to promote the online booking platform construction project of the listed vaccine with Coching Holdings, and will continue to cooperate in the fields of health science, vaccine code, full traceability and so on.
Paint Ye Qing Source: Euro Copyright Notice: All text, images and audio and video materials on this website that indicate "Source: Met Medical" or "Source: MedSci Original" are owned by Metz Medical and may not be reproduced by any media, website or individual without authorization, and shall be reproduced with the words "Source: Mets Medicine".
all reprinted articles on this website are for the purpose of transmitting more information and clearly indicate the source and author, and media or individuals who do not wish to be reproduced may contact us and we will delete them immediately.
reproduce content at the same time does not represent the position of this site.
leave a message here.